Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?

Pa ,  k Jihye ,  천재희

Gut and Liver

2021 .09

Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?

오규만 ,  문원

Intestinal research

2020 .01

Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease

Kang Eun Ae ,  Cheon Jae Hee

Gut and Liver

2022 .07

Factors Contributing to the Preference of Korean Patients with Crohn’s Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)

Eun Soo Kim ,  Kyeong Ok Kim ,  Byung Ik Jang 외 16명

Gut and Liver

2016 .01

The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn’s Disease

심정옥 ,  Yoon Tae Jeen

Gut and Liver

2018 .01

Lesson from Real-World Experience: Optimal Treatment with Anti-Tumor Necrosis Factor for Ulcerative Colitis

Chun Jaeyoung

Gut and Liver

2021 .11

Comparing Effectiveness Rituximab (MabtheraⓇ) to Other Second-line Biologics for Rheumatoid Arthritis Treatment in Patients Refractory to or Intolerant of First-line Anti-tumor Necrosis Factor Agent: An Observational Study

박용욱 ,  김기조 ,  양형인 외 9명

대한류마티스학회지

2017 .01

Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis

Takumi Kawaguchi ,  Takuji To ,  imu 외 1명

Clinical and Molecular Hepatology

2022 .04

Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study

Song Joo Hye ,  Kang Eun Ae ,  Pa 외 16명

Gut and Liver

2021 .09

Fatal infections in older patients with inflammatory bowel disease on anti-tumor necrosis factor therapy

Way-Seah Lee ,  Najib Azmi ,  Ruey-Te 외 6명

Intestinal research

2017 .01

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet’s Disease

Jihye Pa ,  k ,  천재희

Gut and Liver

2018 .01

Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody

Sang-Hyun Kim ,  Ji-Hyun Pa ,  k 외 10명

Immune Network

2022 .10

Multiple Autoimmune Skin Manifestations in a Patient with Crohn’s Disease Treated with a Tumor Necrosis Factor-Alpha Blocker

Edoa ,  do Zatt ,  a 외 8명

Annals of Dermatology

2015 .01

Efficacy and Safety of Anti-Tumor Necrosis Factor- Alpha Agents for Patients with Intestinal Behcet’s Disease: A Systematic Review and Meta-Analysis

Qingfeng Zhang ,  Chunyan Ma ,  Rong 외 6명

Yonsei Medical Journal

2022 .02

Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients

차재명 ,  박동일 ,  박상형 외 3명

Journal of Korean Medical Science

2017 .01

The Impact of the Amendment of the Korean National Health Insurance Reimbursement Criteria for Anti-tumor Necrosis Factor- Agents on Treatment Pattern, Clinical Response and Persistence in Patients With Rheumatoid Arthritis

Yunkyung Kim ,  Geun-Tae Kim ,  Young Sun Suh 외 3명

대한류마티스학회지

2020 .01

Impact of anti-tumor necrosis factor treatment on lipid profiles in Korean patients with ankylosing spondylitis

권인범 ,  최나연 ,  신지휘 외 3명

대한류마티스학회지

2024 .01

Development of Rheumatoid Nodules after Anti-Tumor Necrosis Factor-α Treatment with Adalimumab for Rheumatoid Arthritis

신성식 ,  정기양 ,  김대석

Annals of Dermatology

2016 .01

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy

천재희 ,  한소정 ,  강은애 외 5명

Yonsei Medical Journal

2023 .02

Multifocality and Bilaterality of Papillary Thyroid Microcarcinoma

소윤경 ,  김명우 ,  손영익

Clinical and Experimental Otorhinolaryngology

2015 .01